Public consultations on NOTICE FROM THE COMMISSION ON ASPECTS OF THE APPLICATION OF ARTICLE 3, 5 AND 7 OF REGULATION (EC) NO 141/2000 ON ORPHAN MEDICINAL PRODUCTS
The European Commission is proposing to review the 2003 Communication on orphan medicinal products to streamline the regulatory framework and to adapt the ConsultationCommunication to technical progress. The 2003 Communication will be replaced by a notice.
Go to: REGULATION (EC) NO 141/2000
Period of consultation:

  • From 16 November 2015 to  15 February 2016

The consultation documents:
NOTICE FROM THE COMMISSION ON ASPECTS OF THE APPLICATION OF ARTICLE 3, 5 AND 7 OF REGULATION (EC) NO 141/2000 ON ORPHAN MEDICINAL PRODUCTSpdf(59 KB)
How to submit your contribution:

  • Please, submit your response to these public consultations by 15 February 2016 at the latest. Contributions may be sent by e-mail to SANTE-PHARMACEUTICALS-D5@ec.europa.eu
  • In your response, please make reference to the number of the consultation topics and/or the line of the consultation document.

[Read more…]